Lattice Biologics (TSXV:LBL.H) Operating Cash Flow per Share : C$-0.00 (TTM As of Jun. 2021)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Operating Cash Flow per Share?

Lattice Biologics's operating cash flow per share for the three months ended in Jun. 2021 was C$0.00. Lattice Biologics's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2021 was C$-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Lattice Biologics's Operating Cash Flow per Share or its related term are showing as below:

TSXV:LBL.H's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 2.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Lattice Biologics Operating Cash Flow per Share Historical Data

The historical data trend for Lattice Biologics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Operating Cash Flow per Share Chart

Lattice Biologics Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Sep16

Sep17

Sep18

Sep19

Sep20

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.06

-0.01

0.01

Lattice Biologics Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	0.01	-	-0.01	-

Competitive Comparison of Lattice Biologics's Operating Cash Flow per Share

For the Medical Devices subindustry, Lattice Biologics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lattice Biologics's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Price-to-Operating-Cash-Flow falls into.

Lattice Biologics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Lattice Biologics's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2020 is calculated as

Operating Cash Flow per Share (A: Sep. 2020 )	=	Cash Flow from Operations (A: Sep. 2020 )	/	Shares Outstanding (Diluted Average) (A: Sep. 2020 )
	=	0.709	/	102.576
	=	0.01

Lattice Biologics's Operating Cash Flow per Share for the quarter that ended in Sep. 2020 is calculated as

Operating Cash Flow per Share (Q: Jun. 2021 )	=	Cash Flow from Operations (Q: Jun. 2021 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2021 )
	=	0.002	/	128.218
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00

Lattice Biologics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines